befiradol
Befiradol was discovered and developed by Pierre Fabre Médicament, a French pharmaceuticals company.It is an experimental drug being studied for the treatment of levodopa-induced dyskinesia. Reference standards of Befiradol API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Befiradol
[catalogue_number] => PA 02 98000
[category_ids] => ,78,89,80,79,
[chemical_name] =>
[weight] => 393.86
[form] => C20H22ClF2N3O
[cas] => 208110-64-9
[pslug] => 208110-64-9-befiradol-api-pa0298000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 02 98000
Molecular Formula : C20H22ClF2N3O
Molecular Weight : 393.86
